These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


530 related items for PubMed ID: 32155491

  • 1. Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ1-42 aggregation.
    Plazas E, Hagenow S, Avila Murillo M, Stark H, Cuca LE.
    Bioorg Chem; 2020 May; 98():103722. PubMed ID: 32155491
    [Abstract] [Full Text] [Related]

  • 2. Metabolomic profiling of Zanthoxylum species: Identification of anti-cholinesterase alkaloids candidates.
    Plazas E, Casoti R, Avila Murillo M, Batista Da Costa F, Cuca LE.
    Phytochemistry; 2019 Dec; 168():112128. PubMed ID: 31557705
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents.
    Ye C, Xu R, Cao Z, Song Q, Yu G, Shi Y, Liu Z, Liu X, Deng Y.
    Bioorg Chem; 2021 Jun; 111():104895. PubMed ID: 33887586
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z, Wang K, Shi J, Liu W, Tan Z.
    Eur J Med Chem; 2019 Sep 15; 178():726-739. PubMed ID: 31229875
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
    Zhang X, Song Q, Cao Z, Li Y, Tian C, Yang Z, Zhang H, Deng Y.
    Bioorg Chem; 2019 Jun 15; 87():395-408. PubMed ID: 30921741
    [Abstract] [Full Text] [Related]

  • 6. Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's disease.
    Godyń J, Zaręba P, Łażewska D, Stary D, Reiner-Link D, Frank A, Latacz G, Mogilski S, Kaleta M, Doroz-Płonka A, Lubelska A, Honkisz-Orzechowska E, Olejarz-Maciej A, Handzlik J, Stark H, Kieć-Kononowicz K, Malawska B, Bajda M.
    Bioorg Chem; 2021 Sep 15; 114():105129. PubMed ID: 34217977
    [Abstract] [Full Text] [Related]

  • 7. Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.
    Bowroju SK, Penthala NR, Lakkaniga NR, Balasubramaniam M, Ayyadevara S, Shmookler Reis RJ, Crooks PA.
    Bioorg Med Chem; 2021 Sep 01; 45():116311. PubMed ID: 34304133
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
    Košak U, Strašek N, Knez D, Jukič M, Žakelj S, Zahirović A, Pišlar A, Brazzolotto X, Nachon F, Kos J, Gobec S.
    Eur J Med Chem; 2020 Jul 01; 197():112282. PubMed ID: 32380361
    [Abstract] [Full Text] [Related]

  • 10. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
    Khan NA, Khan I, Abid SMA, Zaib S, Ibrar A, Andleeb H, Hameed S, Iqbal J.
    Med Chem; 2018 Jul 01; 14(1):74-85. PubMed ID: 28545383
    [Abstract] [Full Text] [Related]

  • 11. Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors.
    Passos CS, Simões-Pires CA, Nurisso A, Soldi TC, Kato L, de Oliveira CM, de Faria EO, Marcourt L, Gottfried C, Carrupt PA, Henriques AT.
    Phytochemistry; 2013 Feb 01; 86():8-20. PubMed ID: 23261030
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
    Tripathi RKP, M Sasi V, Gupta SK, Krishnamurthy S, Ayyannan SR.
    J Enzyme Inhib Med Chem; 2018 Dec 01; 33(1):37-57. PubMed ID: 29098902
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F, Wang ZM, Wu JJ, Wang J, Xie SS, Lan JS, Xu W, Kong LY, Wang XB.
    J Enzyme Inhib Med Chem; 2016 Dec 01; 31(sup3):41-53. PubMed ID: 27384289
    [Abstract] [Full Text] [Related]

  • 15. Attenuating Aβ1-42-induced toxicity by a novel acetylcholinesterase inhibitor.
    Mishra N, Sasmal D, Singh KK.
    Neuroscience; 2013 Oct 10; 250():309-19. PubMed ID: 23872389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E, Sadeghpour H, Nadri H, Sakhteman A, Tüylü Küçükkılınç T, Miri R, Edraki N.
    Bioorg Chem; 2019 Aug 10; 89():103006. PubMed ID: 31158577
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.